# Research Idea Ranking

**Generated:** 2026-02-12T17:33:43.813899
**Model:** openai/gpt-5.2 (reasoning: high)
**Tokens:** 9362

---

### Rankings

**#1: The Quiet Life Goes Macro: Anti-Takeover Laws and the Rise of Market Power**
- **Score: 70/100**
- **Strengths:** Compelling attempt to link a well-identified corporate-governance shock to secular macro outcomes (dynamism, concentration, labor share). Data are long-panel, high quality, and treatment has ample cluster count (~33).
- **Concerns:** The big risk is **exposure mismatch**: BC statutes apply by **state of incorporation**, while BDS/CBP/BEA outcomes are by **state of establishment/location**—this can attenuate effects or even break interpretation (especially for Delaware). Also coincident corporate-law changes (other anti-takeover statutes) could confound.
- **Novelty Assessment:** **Moderately high.** Anti-takeover laws are heavily studied at the firm/plant level (BM 2003; Giroud-Mueller; etc.), but the *macro market power / labor share* link is much less developed and could be a meaningful contribution if exposure is handled carefully.
- **DiD Assessment (CS staggered DiD):**
  - **Pre-treatment periods:** **Strong** (outcomes back to late 1970s; earliest treatment mid-1980s).
  - **Selection into treatment:** **Marginal** (adoption plausibly related to takeover pressure/political economy; some documented lobbying).
  - **Comparison group:** **Strong** (meaningful set of never-treated and not-yet-treated states; can also do leave-one-out and region-specific checks).
  - **Treatment clusters:** **Strong** (~33 treated states).
  - **Concurrent policies:** **Marginal** (control-share laws, constituency statutes, other governance reforms; must measure and net out).
  - **Outcome-Policy Alignment:** **Marginal** (**key issue**: incorporation-based treatment vs location-based outcomes; needs an “exposure” design).
  - **Data-Outcome Timing:** **Marginal** (BDS/CBP are tied to the week including **March 12**; many statutes become effective mid-year—first “treated year” may be partial/zero exposure unless lagged).
  - **Outcome Dilution:** **Marginal** (affected firms may be a modest share of state employment in some states; could be very small in Delaware-like cases).
- **Recommendation:** **PURSUE (conditional on: (i) constructing state-year exposure = share of state employment in firms incorporated in-state (or restricting to states where incorporation≈location); (ii) explicitly controlling for other anti-takeover statutes and major contemporaneous corporate-law changes; (iii) timing treatment to when firms actually face the moratorium, with lags relative to March-based outcomes).**

---

**#2: The Green Transition’s Hidden Cost: Renewable Portfolio Standards and Manufacturing Reallocation**
- **Score: 62/100**
- **Strengths:** High policy relevance and good data (QCEW/BDS/BEA/EIA) with enough treated clusters (~29). The “reallocation vs pure loss” framing is useful for climate-policy evaluation.
- **Concerns:** RPS adoption is politically/endogenously selected (green states differ systematically), and RPS often comes bundled with **electricity-market reforms and other climate policies**, threatening DiD credibility. Treatment timing is also conceptually fuzzy because mandates phase in—“adoption year” may not equal first binding exposure.
- **Novelty Assessment:** **Moderate.** There is already serious work on RPS → electricity prices and some labor-market outcomes (e.g., Curtis and related work). The *state-level sectoral reallocation* angle is incremental but potentially still publishable if the identification is unusually careful.
- **DiD Assessment (CS staggered DiD):**
  - **Pre-treatment periods:** **Strong** (QCEW back to ~1990; earliest RPS ~1997).
  - **Selection into treatment:** **Marginal** (policy adoption correlates with preferences, industrial mix, and pre-trends).
  - **Comparison group:** **Marginal** (never-RPS states are disproportionately South/Plains and may be structurally different).
  - **Treatment clusters:** **Strong** (~29).
  - **Concurrent policies:** **Marginal** to **Weak** (risk of coincident deregulation/restructuring, net metering, subsidies, RGGI/CA cap-and-trade; must measure explicitly—could be a dealbreaker in some states/years).
  - **Outcome-Policy Alignment:** **Strong** (manufacturing employment/GDP shares and entry/exit map directly to the hypothesized cost channel).
  - **Data-Outcome Timing:** **Marginal** (RPS obligations ramp; need “first compliance/binding year” rather than enactment).
  - **Outcome Dilution:** **Strong** for manufacturing outcomes (you are measuring the affected sector directly; not a tiny subgroup outcome).
- **Recommendation:** **CONSIDER (conditional on: (i) redefining treatment as first binding compliance year / stringency thresholds; (ii) explicitly coding and controlling for electricity restructuring and major climate/industrial policies; (iii) showing robust pre-trends within matched samples or via synthetic-control-type validation).**

---

**#3: Automatic Stabilizers in Practice: State EITCs and Local Fiscal Multipliers**
- **Score: 55/100**
- **Strengths:** Strong policy relevance (automatic stabilizers) and plenty of adoption/generosity variation over time. A recession-interaction design is conceptually coherent.
- **Concerns:** Biggest issue is **measurement feasibility and timing**: true consumption measures at county-month/year are hard to get consistently, and EITC impacts hit when refunds arrive (typically **Feb–Apr of the following year**), so naïve “policy-year” coding can mechanically attenuate estimates. Also, state EITCs often move alongside other tax/transfer changes.
- **Novelty Assessment:** **Moderate-low to moderate.** EITC is extremely crowded; the “macro stabilizer/multiplier” angle is less saturated than micro labor-supply work, but there is related aggregate/state-level work and it will be held to a high bar.
- **DiD Assessment (CS staggered DiD / triple diff):**
  - **Pre-treatment periods:** **Strong** (adoptions begin late 1980s; outcomes available earlier).
  - **Selection into treatment:** **Marginal** (political economy; may respond to labor-market conditions and poverty trends).
  - **Comparison group:** **Marginal** (still a set of never-treated states, but they may differ politically/economically).
  - **Treatment clusters:** **Strong** (~33 + DC).
  - **Concurrent policies:** **Marginal** (minimum wage, UI, SNAP/TANF changes, other tax credits).
  - **Outcome-Policy Alignment:** **Marginal** (aggregate retail sales/employment are indirect proxies for transfers to eligible households; works only with careful scaling by eligibility/share).
  - **Data-Outcome Timing:** **Marginal** (potentially **Weak** if not corrected): refunds lag tax year; annual outcomes may be misaligned unless treatment is shifted to refund season/exposure year.
  - **Outcome Dilution:** **Marginal** (EITC-eligible households are plausibly ~15–25% of households; effects on total county employment/GDP can be diluted).
- **Recommendation:** **CONSIDER (conditional on: (i) securing a consistent, high-frequency consumption proxy across places/years—e.g., taxable sales receipts, credit/debit panel data, or retailer scanner data; (ii) aligning treatment to refund receipt timing; (iii) scaling effects by EITC exposure/eligibility share and tightly controlling for other contemporaneous state tax/transfer changes).**

---

**#4: Does Monitoring Cure the Epidemic? Prescription Drug Monitoring Programs and Aggregate Labor Supply**
- **Score: 45/100**
- **Strengths:** High policy importance and excellent outcome data (monthly CPS/BLS LFP, BEA, SSA). “Must-access” provisions are a more discrete margin than initial PDMP adoption.
- **Concerns:** **Selection into treatment is likely endogenous to worsening opioid trends**, and the period is packed with confounding opioid policies (pill mill laws, naloxone access, prescribing limits, Medicaid expansion). **Outcome dilution** is severe: opioid misuse is a small share of the population, so state-level LFP moves are hard to attribute and underpowered.
- **Novelty Assessment:** **Moderate.** There is a large PDMP/opioid policy literature; “aggregate LFP” is less common but not so distinct that it overcomes the identification threats.
- **DiD Assessment (CS staggered DiD):**
  - **Pre-treatment periods:** **Strong** (long pre-period available).
  - **Selection into treatment:** **Weak** (states typically adopt/strengthen PDMPs because opioid outcomes are deteriorating).
  - **Comparison group:** **Marginal** (near-universal adoption leaves thin “clean” controls; Missouri-only never-treated for PDMP adoption is not credible as a sole counterfactual).
  - **Treatment clusters:** **Strong** (many states; must-access also many).
  - **Concurrent policies:** **Weak** (dense, overlapping opioid and health policies in the same window).
  - **Outcome-Policy Alignment:** **Marginal** (labor supply is downstream and affected by many forces; requires strong mechanism evidence).
  - **Data-Outcome Timing:** **Strong/Marginal** (monthly outcomes allow alignment to effective dates, but only if coded precisely).
  - **Outcome Dilution:** **Weak** (affected population likely well under 10% of working-age adults; aggregate LFP effects are highly diluted).
- **Recommendation:** **SKIP** (unless redesigned around more local/high-exposure outcomes—e.g., county-by-age/sex LFP, disability inflows in high-opioid counties—and a plausibly exogenous policy trigger or instrument).

---

**#5: Data Privacy as Industrial Policy: State Breach Notification Laws and the Digital Economy**
- **Score: 32/100**
- **Strengths:** Potentially novel on aggregate outcomes; universal staggered adoption offers apparent statistical power.
- **Concerns:** **Outcome-policy alignment is the dealbreaker**: breach notification laws are triggered by *residency of affected consumers* and apply to firms nationwide serving those residents, so the treatment is not cleanly “state-economy facing” in a way that should move in-state tech employment/GDP. Adoption is also plausibly driven by breaches/tech conditions, and “information sector” is a noisy proxy for the digital economy.
- **Novelty Assessment:** **High** on the aggregate-geography question, but novelty cannot compensate for weak interpretability.
- **DiD Assessment (CS staggered DiD):**
  - **Pre-treatment periods:** **Strong** (early 2000s start; outcomes available earlier).
  - **Selection into treatment:** **Marginal** (likely correlated with breach incidence and state political/legal environment).
  - **Comparison group:** **Marginal** (uses not-yet-treated states; no never-treated, which is workable but raises reliance on functional-form/parallel-trends assumptions).
  - **Treatment clusters:** **Strong** (50 states).
  - **Concurrent policies:** **Marginal** (other privacy/security laws and state tech initiatives may co-move).
  - **Outcome-Policy Alignment:** **Weak** (consumer-residency-based compliance + multi-state firms → state-of-location outcomes don’t map cleanly to treatment intensity).
  - **Data-Outcome Timing:** **Marginal** (effective dates vary; annual aggregation risks partial exposure).
  - **Outcome Dilution:** **Marginal** (effects likely diffuse and small relative to total state employment/output).
- **Recommendation:** **SKIP** (unless reframed around outcomes that directly track the law’s mechanism at the consumer/state-residency level—e.g., identity theft reports, consumer credit freezes, breach incidence reporting—rather than “digital economy growth”).  

---

### Summary

This is a decent batch with one clearly fundable direction: **Idea 1** has the best combination of potential novelty and tractable data, but it *must* solve the incorporation-vs-location exposure problem and timing. **Ideas 2 and 3** are plausible but face classic staggered-policy DiD threats (endogenous adoption, bundled policies, and timing alignment—especially for EITC refunds). **Ideas 4 and 5** have “Weak” criteria (opioid policy confounding/dilution; and breach-law outcome misalignment), so I would not advance them without major redesign.